Conversations in Lung Cancer Research

From Clinical Research to Leadership: A Conversation with Prof. Michael Boyer


Listen Later

In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore interviews Prof Michael Boyer, AM about his extensive career in medical oncology and his current role as CEO of Chris O'Brien Lifehouse. They discuss his early interest in oncology, the influential mentors in his career, and the evolution of lung cancer treatment and research. Michael shares his perspectives on leadership in medical and research roles, the importance of building relationships, and the balance between industry-sponsored and cooperative group research. They also touch upon professional challenges, emotional resilience in oncology, and Michael's vision for the future of his career and the field of oncology.

 

(00:00) Welcome and Introduction

(01:04 )Guest Introduction: Professor Michael Boyer

(02:25) Michael Boyer's Early Career and Mentorship

(07:27) Leadership Roles and Challenges

(11:33) Involvement in Clinical Research

(21:03) Emotional Aspects of Oncology

(29:38) Future of Oncology and Career Advice

(33:06) Conclusion and Farewell

Resources and Links:

International Association for the Study of Lung Cancer https://www.iaslc.org/

Chris O'Brien Lifehouse https://www.mylifehouse.org.au/

Schwartz Rounds https://www.theschwartzcenter.org/programs/schwartz-rounds/

...more
View all episodesView all episodes
Download on the App Store

Conversations in Lung Cancer ResearchBy Thoracic Oncology Group Of Australasia (TOGA)


More shows like Conversations in Lung Cancer Research

View all
Conversations by ABC listen

Conversations

862 Listeners

Lung Cancer Update by Dr. Neil Love

Lung Cancer Update

32 Listeners

Prostate Cancer Update by Dr. Neil Love

Prostate Cancer Update

14 Listeners

ASCO Daily News by American Society of Clinical Oncology (ASCO)

ASCO Daily News

58 Listeners

Lung Cancer Considered by IASLC

Lung Cancer Considered

27 Listeners

JCO Precision Oncology Conversations by American Society of Clinical Oncology (ASCO)

JCO Precision Oncology Conversations

3 Listeners

Lung Cancer Considered by IASLC

Lung Cancer Considered

27 Listeners